Daniel Lin study shows two biomarkers in urine are associated with cancers likely to be aggressive among men who take a 'watchful waiting' approach
Feb. 6, 2012
| By Kristen Woodward
Initial results of a multicenter study coordinated by Hutchinson Center researchers indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to be aggressive and potentially life-threatening among men who take a "watchful waiting," or active-surveillance, approach to manage their disease. Ultimately, these markers may lead to the development of a urine test that could complement prostate biopsy for predicting disease aggressiveness and progression.
Clinical Research Division's Philip Greenberg honored for pioneering work to bring adoptive T-cell therapy from bench to bedside
Sept. 26, 2011
Dr. Philip Greenberg, head of the Fred Hutchinson Cancer Research Center’s Immunology Program in the Clinical Research Division, is the joint recipient of the 2011 William B. Coley Award for Distinguished Research in Tumor Immunology for his pioneering research in adoptive T-cell therapy.
Medical scientist Maria Corinna Palanca-Wessels, working to defeat ovarian cancer, is among three Pacific Northwest scientists in the inaugural class of Kuni Scholars
July 11, 2011
| By Kristen Woodward
Dr. Maria Corinna Palanca-Wessels of the Fred Hutchinson Cancer Research Center is one step closer to her goal of making ovarian tumors more susceptible to chemotherapy thanks to a two-year, $200,000 award from the Wayne D. Kuni and Joan E. Kuni Foundation of Vancouver, Wash., and the Kuni family (through the 3725 Fund of the Oregon Community Foundation).
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.